Jiangxi Fushine Pharmaceutical Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300497
  • 1d-5.43%
  • 1w-7.14%
  • 1m-6.61%
  • 1y-37.91%
ATH
  • ATH Price$24.76
  • ATH Date2021-09-24
  • % since ATH-66.92%
  • % to ATH202.32%
ATL
  • ATL Price$3.60
  • ATL Date2015-12-22
  • % from ATL127.43%
  • Last Low Price$6.02
  • Last Low Date2024-02-05
  • % From Last Low36.05%
IPO
  • IPO Price$9.88
  • % Current ROI USD-17.06%
  • ATH Price$24.76
  • % ROI ATH 68,756.77%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300497"]

Key Data [addtoany]

Current price $8.19
Sector Healthcare
Industry Biotechnology
Today's High/Low $8.7/$8.11
Volume 6,783,925.00
Previous Close $8.66
52 Week High/Low $14.33/$5.62
Market Cap 4,598,041,600.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$8.19
[addtoany]

Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally.
The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. The company was founded in 2002 and is based in Jingdezhen, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity